Treating Alzheimer’s disease with monoclonal antibodies: current status and outlook for the future

by Prins, Niels D, Scheltens, Philip
Published 2013

Amyloid imaging in prodromal Alzheimer's disease

by Ossenkoppele, Rik, van Berckel, Bart NM, Prins, Niels D
Published 2011

Amyloid imaging in clinical trials

by Ossenkoppele, Rik, Prins, Niels D, van Berckel, Bart NM
Published 2013

The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized con...

by Prins, Niels D, van der Flier, Wiesje A, Knol, Dirk L, Fox, Nick C, Brashear, H Robert, Nye, Jeffrey S, Barkhof, Frederik, Scheltens, Philip
Published 2014

The influence of cerebral small vessel disease on default mode network deactivation in mild cognitive impairment☆

by Papma, Janne M., den Heijer, Tom, de Koning, Inge, Mattace-Raso, Francesco U., van der Lugt, Aad, van der Lijn, Fedde, van Swieten, John C., Koudstaal, Peter J., Smits, Marion, Prins, Niels D.
Published 2012

Cerebral perfusion in the predementia stages of Alzheimer’s disease

by Binnewijzend, Maja A. A., Benedictus, Marije R., Kuijer, Joost P. A., van der Flier, Wiesje M., Teunissen, Charlotte E., Prins, Niels D., Wattjes, Mike P., van Berckel, Bart N.M., Scheltens, Philip, Barkhof, Frederik
Published 2015